Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Einat B Vitner

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Advanced Healthcare Materials|June 17, 2025
In Vivo Accumulation of Regulatory T Cells Using Eliglustat-Loaded CryogelsEinat B Vitner, Giovanni Bovone, Wei-Hung Jung, et al.
Current Issues in Molecular Biology|October 27, 2023
Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2Noam Erez, Hagit Achdout, Yfat Yahalom-Ronen, et al.
The Journal of Pathology|May 29, 2016
Delineating pathological pathways in a chemically induced mouse model of Gaucher diseaseAyelet Vardi, Hila Zigdon, Anna Meshcheriakova, et al.
Journal of the American Society of Nephrology : JASN|June 11, 2021
Human Kidney Spheroids and Monolayers Provide Insights into SARS-CoV-2 Renal InteractionsDorit Omer, Oren Pleniceanu, Yehudit Gnatek, et al.
Plos Pathogens|December 20, 2021
SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infectionAbigael Eva Chaouat, Hagit Achdout, Inbal Kol, et al.
Nature Communications|October 6, 2021
Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunityHagit Achdout, Einat B Vitner, Boaz Politi, et al.
Nature Communications|February 12, 2021
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibodyRonit Rosenfeld, Tal Noy-Porat, Adva Mechaly, et al.
Nature Communications|December 17, 2020
A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challengeYfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, et al.
Science (New York, N.Y.)|November 9, 2023
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsMelissa L Boby, Daren Fearon, Matteo Ferla, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Advanced Healthcare Materials|June 17, 2025
In Vivo Accumulation of Regulatory T Cells Using Eliglustat-Loaded CryogelsEinat B Vitner, Giovanni Bovone, Wei-Hung Jung, et al.
Current Issues in Molecular Biology|October 27, 2023
Identification of T-Cell Epitopes Using a Combined In-Silico and Experimental Approach in a Mouse Model for SARS-CoV-2Noam Erez, Hagit Achdout, Yfat Yahalom-Ronen, et al.
The Journal of Pathology|May 29, 2016
Delineating pathological pathways in a chemically induced mouse model of Gaucher diseaseAyelet Vardi, Hila Zigdon, Anna Meshcheriakova, et al.
Journal of the American Society of Nephrology : JASN|June 11, 2021
Human Kidney Spheroids and Monolayers Provide Insights into SARS-CoV-2 Renal InteractionsDorit Omer, Oren Pleniceanu, Yehudit Gnatek, et al.
Plos Pathogens|December 20, 2021
SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infectionAbigael Eva Chaouat, Hagit Achdout, Inbal Kol, et al.
Nature Communications|October 6, 2021
Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunityHagit Achdout, Einat B Vitner, Boaz Politi, et al.
Nature Communications|February 12, 2021
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibodyRonit Rosenfeld, Tal Noy-Porat, Adva Mechaly, et al.
Nature Communications|December 17, 2020
A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challengeYfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, et al.
Science (New York, N.Y.)|November 9, 2023
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitorsMelissa L Boby, Daren Fearon, Matteo Ferla, et al.
Pageof 3